help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism, doi:10.1210/jc.2005-0419
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
90/11/6113    most recent
Author Manuscript (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kublickiene, K.
Right arrow Articles by Poston, L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kublickiene, K.
Right arrow Articles by Poston, L.
Related Collections
Right arrow Cardiovascular Endocrinology
Right arrow Female Endocrinology
The Journal of Clinical Endocrinology & Metabolism Vol. 90, No. 11 6113-6122
Copyright © 2005 by The Endocrine Society

Small Artery Endothelial Dysfunction in Postmenopausal Women: In Vitro Function, Morphology, and Modification by Estrogen and Selective Estrogen Receptor Modulators

Karolina Kublickiene, Eimantas Svedas, Britt-Marie Landgren, Milita Crisby, Nasrin Nahar, Henry Nisell and Lucilla Poston

Institution for Clinical Science, Intervention, and Technology (K.K., E.S., B.-M.L., H.N.), Department of Obstetrics and Gynecology, and Department of Neurotec (M.C., N.N.), Section for Experimental Geriatrics, Karolinska Institutet, Karolinska University Hospital-Huddinge, 14186 Stockholm, Sweden; and Maternal and Fetal Research Unit (L.P.), Division of Reproductive Health, Endocrinology, and Development, King’s College London, London SE1 7EH, United Kingdom

Address all correspondence and requests for reprints to: Karolina Kublickiene, M.D., Ph.D., Institution for Clinical Science, Intervention, and Technology, Department of Obstetrics and Gynecology, Karolinska Institute, Karolinska University Hospital-Huddinge Campus, 14186 Stockholm, Sweden. E-mail: karolina.kublickiene{at}klinvet.ki.se.

Objective: Our objective was to assess vascular endothelial function and morphology in resistance vasculature from healthy pre- and postmenopausal women in vitro and to determine potential mechanisms of vascular protection by estrogenic compounds.

Methods: Arteries (~220 µm) were dissected from sc fat biopsies obtained from healthy premenopausal and postmenopausal women. Flow-mediated dilatation, agonist-induced endothelium-dependent and -independent relaxation, and myogenic responses to changes in intraluminal pressure were evaluated before and after incubation (3 h) with 17ß-estradiol, propyl pyrazole triol [a selective estrogen receptor-{alpha} (ER{alpha}) agonist], raloxifene (a second-generation selective ER modulator), and the phytoestrogen genistein, using pressure myography technique. In addition, endothelial morphology was assessed in arteries from pre- and postmenopausal women, and distribution of ERs within the artery wall from postmenopausal women was evaluated.

Results: Functional and morphological disturbances of endothelial function were observed in small arteries from postmenopausal women. Incubation with 17ß-estradiol improved postmenopausal resistance artery function, an effect mimicked by propyl pyrazole triol but not raloxifene or genistein. Immunohistochemical staining revealed similar expression of ER{alpha} and ERß in the smooth muscle of arteries from postmenopausal women; however, ER{alpha} was dominant in endothelium.

Conclusions: The resistance arteries from postmenopausal women show functional and morphological abnormalities. ER{alpha} may contribute to vascular protection by estrogens in the peripheral resistance circulation in postmenopausal women. Selective ER{alpha} agonists warrant further investigation as therapeutic agents for prevention of cardiovascular disease in postmenopausal women.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
K. Kublickiene, X.-D. Fu, E. Svedas, B.-M. Landgren, A. R. Genazzani, and T. Simoncini
Effects in Postmenopausal Women of Estradiol and Medroxyprogesterone Alone and Combined on Resistance Artery Function and Endothelial Morphology and Movement
J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1874 - 1883.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
X.-D. Fu, M. Flamini, A. M. Sanchez, L. Goglia, M. S. Giretti, A. R. Genazzani, and T. Simoncini
Progestogens regulate endothelial actin cytoskeleton and cell movement via the actin-binding protein moesin
Mol. Hum. Reprod., April 1, 2008; 14(4): 225 - 234.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Douglas, M. Natalia Cruz, L. Poston, J.-A. Gustafsson, and K. Kublickiene
Functional characterization and sex differences in small mesenteric arteries of the estrogen receptor- knockout mouse
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R112 - R120.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
S. P. Duckles, D. N. Krause, C. Stirone, and V. Procaccio
Estrogen and mitochondria: a new paradigm for vascular protection?
Mol. Interv., February 1, 2006; 6(1): 26 - 35.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2005 by The Endocrine Society